Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset

October 21, 2024

The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize CV-01 in the Republic of […]

(LEAD) Russia defends N. Korea ties, denies clarifying use of N. Korean soldiers in Ukraine

October 21, 2024

Russia said Monday it will continue to strengthen ties with North Korea, while declining to confirm South Korea’s intelligence report claiming North Korea had sent troops to support Russian forces in Ukraine.

On Friday, South Korea’s National Intell…

Foreign ministry calls in Russia’s top envoy to Seoul over N. Korea’s troop dispatch

October 21, 2024

The foreign ministry called in the top Russian envoy to South Korea on Monday to express regret over North Korea’s deployment of its soldiers to fight Russia’s war in Ukraine.

First Vice Foreign Minister Kim Hong-kyun delivered the government’s posi…